| Revenues | | 14,191.00 | 13,203.00 | 14,366.00 | 13,467.00 |
| | 1,043.00 | 951.00 | - | - |
| Research and Development | | 1,043.00 | 951.00 | - | - |
| Costs And Expenses | | 12,301.00 | 11,280.00 | 12,592.00 | 12,354.00 |
| Operating Income/Loss | | 1,890.00 | 1,923.00 | 1,774.00 | 1,113.00 |
| Income/Loss From Equity Method Investments | | -21.00 | -20.00 | -14.00 | -14.00 |
| Income/Loss From Continuing Operations Before Tax | | 3,277.00 | 496.00 | 291.00 | 2,620.00 |
| Income Tax Expense/Benefit, Deferred | | 665.00 | 106.00 | -287.00 | -4,167.00 |
| Income Tax Expense/Benefit | | 840.00 | 194.00 | -40.00 | -4,046.00 |
| | 2,416.00 | 282.00 | 317.00 | 6,652.00 |
| Attributable To Parent | | 2,394.00 | 263.00 | 296.00 | 6,626.00 |
| Available To Common Stockholders, Basic | | 2,394.00 | 263.00 | 296.00 | 6,626.00 |
| Attributable To Noncontrolling Interest | | 22.00 | 19.00 | 21.00 | 26.00 |
| Basic Average Shares | | 2,036.46 | 2,052.19 | -3.97 | 2,084.18 |
| Diluted Average Shares | | 2,050.23 | 2,071.39 | -4.60 | 2,124.39 |
| Basic Earnings Per Share | | 1.18 | 0.13 | 0.15 | 3.18 |
| Diluted Earnings Per Share | | 1.17 | 0.13 | 0.16 | 3.11 |